Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins. NHS England ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Jacob is a Consultant in Emergency Physician at Hampshire Hospitals Foundation Trust where he works clinically at Basingstoke and Winchester sites. Prior to his appointment at NICE he was the Clinical ...

The new modifier was introduced in 2022 to allow extra weight to be given to medicines that address severe diseases. It ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Elacestrant for treating oestrogen receptor-positive, HER2-negative advanced breast cancer with an ESR1 mutation after at least 1 endocrine treatment [ID6225] Draft guidance Technology appraisal ...

All NICE products on people with learning disabilities. Includes any guidance and quality standards.